James Leal - Feb 27, 2024 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Chief Manufacturing Officer
Signature
/s/ Rachel Malina, Attorney-in-Fact for James A. Leal
Stock symbol
TNDM
Transactions as of
Feb 27, 2024
Transactions value $
-$3,418
Form type
4
Date filed
2/29/2024, 05:12 PM
Previous filing
Feb 20, 2024
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +309 +2.91% $0.00 10.9K Feb 27, 2024 Direct
transaction TNDM Common Stock Tax liability -$3.42K -125 -1.14% $27.34 10.8K Feb 27, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -309 -49.92% $0.00 310 Feb 27, 2024 Common Stock 309 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2 Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F3 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F4 RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on May 27, 2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.